Search results
Hopkins spinout opens Baltimore lab after $4.5M raise - Baltimore Business Journal
The Business Journals· 6 days agoA Johns Hopkins University spinout has opened a 9,000-square-foot lab in East Baltimore after...
Gateway - Quartz
Quartz· 7 days agoHumira, a monoclonal antibody used to treat arthritis among other conditions, is the most lucrative drug in history. Since entering the market in 2003, it has made its manufacturer ...
Why Are People Promoting Raw Milk?
Rolling Stone via Yahoo News· 6 days agoEarlier this month, the sound of mooing rang out in the chambers of the Louisiana capitol when the House unanimously voted in favor of a bill legalizing...
Sanofi taps Belharra for immune drug research; AstraZeneca’s new cancer drug falls short
BioPharma Dive via Yahoo Finance· 7 days agoBelharra will use its chemoproteomics technology to identify immune drugs for Sanofi. Elsewhere,...
Could a genetic trait delay Alzheimer's?
USA TODAY via Yahoo News· 5 days agoWhat's next for drug development? Arboleda-Velasquez, who works as a Harvard Medical School associate professor of ophthalmology, said his laboratory is using these study findings to develop ...
How America’s Rich Legacy of Fear and Hatred Fuels the Conspiracy Theories of Today
TPM via Yahoo News· 4 days agoWhich isn’t to say that things haven’t improved — I personally believe that what Dickson diagnosed...
Covid-19 Pharma Stars Continue Their Quest To Set New Standards In Cancer Treatment
Benzinga via Yahoo Finance· 7 days agoAstraZeneca PLC (NASDAQ: AZN) kicked off the week by receiving approval from the U.S. Food and Drug...
A Study Allegedly Found Some Bandage Brands Contain PFAS 'Forever Chemicals.' We Checked the...
Snopes via Yahoo News· 7 days agoThe Dangers of PFAS Chemicals PFAS chemicals are used...classified as a human carcinogen. PFAS...
What to Know if You Get a Yellow Jacket Sting
Health via Yahoo News· 3 days agoYellow jacket stings are painful and can cause symptoms that can range from mild to life-threatening. Treatment includes basic first aid and medication.
Day One inks $1.2B biobucks pact for MabCare’s solid tumor ADC
FierceBiotech· 6 days agoDay One Biopharmaceuticals is offering MabCare Therapeutics up to $1.2 billion for exclusive licensing rights to an antibody drug conjugate (ADC) taking aim at solid tumors ...
